Medical Engineering & Physics
Volume 30, Issue 8 , Pages 976-983 , October 2008

Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases

  • Hsin-Yun Hsu

      Affiliations

    • NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
    • ,
  • SilkeWittemann

      Affiliations

    • NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
    • ,
  • E. Marion Schneider

      Affiliations

    • Experimental Anesthesiology, University Hospital, Medical Faculty, Ulm, Germany
    • ,
  • Manfred Weiss

      Affiliations

    • Department of Clinical Anesthesiology, University Hospital, Medical Faculty, Ulm, Germany
    • ,
  • Thomas O. Joos

      Affiliations

    • NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany
    • Corresponding Author InformationCorresponding author at: Biochemistry Department, NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, 72770 Reutlingen, Germany. Tel.: +49 7121 51530 844; fax: +49 7121 51530 16.

Received 1 June 2007 ,Revised 27 November 2007 ,Accepted 11 January 2008.

References 

  1. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol. 2003;10(1):133–139
  2. Dasso J, Lee J, Bach H, Mage RG. A comparison of ELISA and flow microsphere-based assays for quantification of immunoglobulins. J Immunol Methods. 2002;263(1–2):23–33
  3. Prabhakar U, Eirikis E, Davis HM. Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods. 2002;260(1–2):207–218
  4. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol. 2004;110(3):252–266
  5. Templin MF, Stoll D, Bachmann J, Joos TO. Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?. Comb Chem High Throughput Screen. 2004;7(3):223–229
  6. Stoll D, Templin MF, Bachmann J, Joos TO. Protein microarrays: applications and future challenges. Curr Opin Drug Discov Dev. 2005;8(2):239–252
  7. Bochicchio GV, Napolitano LM, Joshi M, Knorr K, Tracy JK, Ilahi O, et al. Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma. 2002;53(2):245–250discussion 250–251
  8. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655
  9. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296(5566):301–305
  10. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554
  11. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28(2):108–121
  12. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med. 1998;157(3 Pt 1):776–784
  13. De Freitas I, Fernandez-Somoza M, Essenfeld-Sekler E, Cardier JE. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest. 2004;125(6):2238–2246
  14. Marshall JC. Clinical trials of mediator-directed therapy in sepsis: what have we learned?. Intensive Care Med. 2000;26(Suppl 1):S75–S83
  15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (I). Crit Care Med. 2004;32(3):858–873
  16. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (II). Intensive Care Med. 2004;30(4):536–555
  17. Heuer JG, Zhang T, Zhao J, Ding C, Cramer M, Justen KL, et al. Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol. 2005;174(11):7141–7146
  18. Heuer JG, Sharma GR, Gerlitz B, Zhang T, Bailey DL, Ding C, et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med. 2004;32(7):1570–1578
  19. Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K, et al. TWEAK is a novel arthritogenic mediator. J Immunol. 2006;177(4):2610–2620
  20. Calvano SE, van der Poll T, Coyle SM, Barie PS, Moldawer LL, Lowry SF. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch Surg. 1996;131(4):434–437
  21. Pruitt JH, Welborn MB, Edwards PD, Harward TR, Seeger JW, Martin TD, et al. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood. 1996;87(8):3282–3288
  22. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167(4):512–520
  23. Leone M, Boutiere B, Camoin-Jau L, Albanese J, Horschowsky N, Mege JL, et al. Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med. 2002;30(4):808–814
  24. Heuer JG, Cummins DJ, Edmonds BT. Multiplex proteomic approaches to sepsis research: case studies employing new technologies. Expert Rev Proteomics. 2005;2(5):669–680
  25. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34(2):374–378
  26. Findlay JW, Smith WC, Lee JW, Nordblom GD, Das I, DeSilva BS, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000;21(6):1249–1273
  27. Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem. 2006;52(9):1651–1659
  28. Kingsmore SF. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov. 2006;5(4):310–320
  29. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001;16(2):83–96
  30. Kriebel F, Wittemann S, Hsu HY, Joos T, Weiss M, Schneider EM. Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock. Ann NY Acad Sci. 2006;1090:168–176
  31. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103(2):565–575
  32. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med. 2003;9(5):517–524
  33. Cinat M, Waxman K, Vaziri ND, Daughters K, Yousefi S, Scannell G, et al. Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma. 1995;39(1):112–118discussion 118–120
  34. Askenasy N, Yolcu ES, Yaniv I, Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood. 2005;105(4):1396–1404
  35. Hotchkiss RS, Schmieg RE, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med. 2000;28(9):3207–3217
  36. Hogg N. Roll, roll, roll your leucocyte gently down the vein. Immunol Today. 1992;13(4):113–115
  37. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med. 1994;42(4):640–651
  38. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care. 1994;9(1):47–71
  39. Sessler CN, Windsor AC, Schwartz M, Watson L, Fisher BJ, Sugerman HJ, et al. Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med. 1995;151(5):1420–1427
  40. Xu H, Gonzalo JA, St Pierre Y, Williams IR, Kupper TS, Cotran RS, et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med. 1994;180(1):95–109
  41. Rogy MA, Oldenburg HS, Coyle S, Trousdale R, Moldawer LL, Lowry SF. Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg. 1996;83(3):396–400
  42. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol. 1995;154(8):3806–3813
  43. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 1995;16(12):569–574
  44. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125–1128
  45. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood. 1992;79(9):2196–2200
  46. Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis: a review. Shock. 2002;18(3):197–211
  47. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006;6(11):813–822
  48. Carrigan SD, Scott G, Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Clin Chem. 2004;50(8):1301–1314
  49. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem. 2005;51(7):1102–1109
  50. Caiazzo RJ, Tassinari OW, Ehrlich JR, Liu BC. Autoantibody microarrays for biomarker discovery. Expert Rev Proteomics. 2007;4(2):261–272
  51. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838

PII: S1350-4533(08)00020-9

doi: 10.1016/j.medengphy.2008.01.003

Medical Engineering & Physics
Volume 30, Issue 8 , Pages 976-983 , October 2008

Article Tools

* Image Usage & Resolution